Avanos Medical, Inc. (AVNS) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Avanos Medical, Inc. · Health Care · ref. ETF XLV · 42 calls · price $24.99
What the company does: Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America.
📈 Avanos Medical, Inc. (AVNS) stock price
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
No recent rating
📊 JPI status : Avanos Medical, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 AVNS price target & analyst consensus — price $24.99
The price target
Highest target—
Median target—
Lowest target—
Current price$24.99
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 0 ratings (last 6 months)
Go deeper on the analysts
🎯 AVNS price target all
All 42 calls, one by one, with our verdict on each firm.
→ See all 42 targets, analyst by analyst💡 The best analysts on AVNS most reliable
Their real reliability on AVNS, firm by firm: who was right, who was wrong.
→ See their reliability on AVNSAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Avanos Medical, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on AVNS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Keybanc ↗ | 0% | 0.0% | 11 |
| Morgan Stanley ↗ | 0% | 0.0% | 15 |
| Raymond James ↗ | 0% | 0.0% | 2 |
📊 What $1,000 invested in Avanos Medical, Inc. would be worth › open the full page
In short — $1,000 invested in Avanos Medical, Inc. 10 years ago would be worth $746 today, i.e. -3%/yr on average. Best year: 2020 (+36%), worst: 2025 (-29%). Price performance, excluding dividends.
If I'd invested $1,000 in Avanos Medical, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,566 | +57% |
| 3 years ago | $921 | -8% |
| 5 years ago | $543 | -46% |
Return by year (Avanos Medical, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +122% | $2,220 (+122%) |
| 2025 | -29% | $1,566 (+57%) |
| 2024 | -29% | $1,111 (+11%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Avanos Medical, Inc.
Loading news…
📋 All analyst calls on AVNS
Filtered on — · ✕ show all
JMP Securities
May 7, 24
■ Market Perform neutral · not a buy
🎯 on AVNS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 7, 25
matures : May 7, 25
■ Sector Weight neutral · not a buy
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jul 24, 24
matures : Jul 24, 24
■ Hold neutral · not a buy · 🎯$25
Price at call : $24.99 — gap to target +0%
Today : $24.99 — gap to target +0%
🎯 on AVNS : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jun 20, 24
matures : Jun 20, 24
CL King
May 22, 23
▲ Buy · 🎯$31
Price at call : $24.99 — upside +24%
Today : $24.99 — upside +24%
Expected +24% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (1 call matured) · 📊 unranked overall
0.0%
stock +0% · XLV +13%
matured May 21, 24
Morgan Stanley ↗
May 4, 23
▼ Underweight · 🎯$26
Price at call : $24.99 — upside +4%
Today : $24.99 — upside +4%
Expected +4% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +6%
matured May 3, 24
Morgan Stanley ↗
Feb 22, 23
▼ Underweight · 🎯$28
Price at call : $24.99 — upside +12%
Today : $24.99 — upside +12%
Expected +12% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +13%
matured Feb 22, 24
Morgan Stanley ↗
Jan 6, 23
▼ Underweight · 🎯$26
Price at call : $24.99 — upside +4%
Today : $24.99 — upside +4%
Expected +4% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +3%
matured Jan 6, 24
▲ Overweight · 🎯$34
Price at call : $24.99 — upside +36%
Today : $24.99 — upside +36%
Expected +36% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV -2%
matured Nov 3, 23
See the other 34 calls, newest to oldest
Morgan Stanley ↗
Oct 11, 22
▼ Underweight · 🎯$24
Price at call : $24.99 — upside -4%
Today : $24.99 — upside -4%
Expected -4% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +6%
matured Oct 11, 23
▲ Overweight · 🎯$38
Price at call : $24.99 — upside +52%
Today : $24.99 — upside +52%
Expected +52% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +2%
matured Aug 10, 23
■ Hold neutral · not a buy · 🎯$28
Price at call : $24.99 — gap to target +12%
Today : $24.99 — gap to target +12%
🎯 on AVNS : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jul 18, 23
matures : Jul 18, 23
Morgan Stanley ↗
Jul 15, 22
▼ Underweight · 🎯$28
Price at call : $24.99 — upside +12%
Today : $24.99 — upside +12%
Expected +12% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +3%
matured Jul 15, 23
Morgan Stanley ↗
May 5, 22
▼ Underweight · 🎯$33
Price at call : $24.99 — upside +32%
Today : $24.99 — upside +32%
Expected +32% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +3%
matured May 5, 23
▲ Overweight · 🎯$41
Price at call : $24.99 — upside +64%
Today : $24.99 — upside +64%
Expected +64% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +1%
matured Feb 24, 23
Morgan Stanley ↗
Jan 7, 22
▼ Underweight · 🎯$36
Price at call : $24.99 — upside +44%
Today : $24.99 — upside +44%
Expected +44% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV -1%
matured Jan 7, 23
Morgan Stanley ↗
Aug 4, 21
▼ Underweight · 🎯$41
Price at call : $24.99 — upside +64%
Today : $24.99 — upside +64%
Expected +64% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV -2%
matured Aug 4, 22
Stephens & Co. ↗
Aug 4, 21
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $24.99 — gap to target +80%
Today : $24.99 — gap to target +80%
🎯 on AVNS : 0% (1 call matured) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Aug 4, 22
matures : Aug 4, 22
▲ Overweight · 🎯$47
Price at call : $24.99 — upside +88%
Today : $24.99 — upside +88%
Expected +88% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV -2%
matured Aug 4, 22
▲ Overweight · 🎯$55
Price at call : $24.99 — upside +120%
Today : $24.99 — upside +120%
Expected +120% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (1 call matured) · 📊 unranked overall
0.0%
stock +0% · XLV +16%
matured Jan 8, 22
Morgan Stanley ↗
Dec 15, 20
▼ Underweight · 🎯$45
Price at call : $24.99 — upside +80%
Today : $24.99 — upside +80%
Expected +80% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +24%
matured Dec 15, 21
Morgan Stanley ↗
Nov 4, 20
▼ Underweight · 🎯$36
Price at call : $24.99 — upside +44%
Today : $24.99 — upside +44%
Expected +44% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +23%
matured Nov 4, 21
▲ Overweight · 🎯$47
Price at call : $24.99 — upside +88%
Today : $24.99 — upside +88%
Expected +88% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +23%
matured Nov 4, 21
▲ Overweight · 🎯$43
Price at call : $24.99 — upside +72%
Today : $24.99 — upside +72%
Expected +72% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +25%
matured Aug 5, 21
Morgan Stanley ↗
May 7, 20
▼ Underweight · 🎯$31
Price at call : $24.99 — upside +24%
Today : $24.99 — upside +24%
Expected +24% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +25%
matured May 7, 21
▲ Overweight · 🎯$45
Price at call : $24.99 — upside +80%
Today : $24.99 — upside +80%
Expected +80% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +21%
matured Apr 27, 21
■ Equal-Weight neutral · not a buy
🎯 on AVNS : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 13, 21
matures : Apr 13, 21
■ Hold neutral · not a buy · 🎯$32
Price at call : $24.99 — gap to target +28%
Today : $24.99 — gap to target +28%
🎯 on AVNS : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Apr 1, 21
matures : Apr 1, 21
Morgan Stanley ↗
Mar 27, 20
▼ Underweight · 🎯$29
Price at call : $24.99 — upside +16%
Today : $24.99 — upside +16%
Expected +16% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +38%
matured Mar 27, 21
Stephens & Co. ↗
Mar 23, 20
▲ Overweight · 🎯$30
Price at call : $24.99 — upside +20%
Today : $24.99 — upside +20%
Expected +20% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (1 call matured) · 📊 on Health : 46.4% · +3.2% (84 calls)
0.0%
stock +0% · XLV +42%
matured Mar 23, 21
Morgan Stanley ↗
Dec 17, 19
▼ Underweight · 🎯$32
Price at call : $24.99 — upside +28%
Today : $24.99 — upside +28%
Expected +28% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +10%
matured Dec 16, 20
■ Hold neutral · not a buy · 🎯$35
Price at call : $24.99 — gap to target +40%
Today : $24.99 — gap to target +40%
🎯 on AVNS : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Nov 6, 20
matures : Nov 6, 20
Raymond James ↗
Nov 6, 19
■ Market Perform neutral · not a buy
🎯 on AVNS : 0% (2 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Nov 5, 20
matures : Nov 5, 20
▲ Overweight · 🎯$48
Price at call : $24.99 — upside +92%
Today : $24.99 — upside +92%
Expected +92% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +17%
matured Nov 5, 20
Raymond James ↗
Aug 7, 19
▲ Outperform · 🎯$48
Price at call : $24.99 — upside +92%
Today : $24.99 — upside +92%
Expected +92% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (2 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
0.0%
stock +0% · XLV +18%
matured Aug 6, 20
▲ Overweight · 🎯$65
Price at call : $24.99 — upside +160%
Today : $24.99 — upside +160%
Expected +160% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +1%
matured Feb 27, 20
▼ Underweight · 🎯$36
Price at call : $24.99 — upside +44%
Today : $24.99 — upside +44%
Expected +44% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
0.0%
stock +0% · XLV +19%
matured Jan 4, 20
▲ Overweight · 🎯$67
Price at call : $24.99 — upside +168%
Today : $24.99 — upside +168%
Expected +168% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (11 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
0.0%
stock +0% · XLV +18%
matured Dec 18, 19
■ Equal-Weight neutral · not a buy · 🎯$69
Price at call : $24.99 — gap to target +176%
Today : $24.99 — gap to target +176%
🎯 on AVNS : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 16, 19
matures : Oct 16, 19
Morgan Stanley ↗
Oct 11, 18
▼ Underweight · 🎯$62
Price at call : $24.99 — upside +148%
Today : $24.99 — upside +148%
Expected +148% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +0%
matured Oct 11, 19
Raymond James ↗
Aug 21, 18
▲ Outperform
Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on AVNS : 0% (2 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
0.0%
stock +0% · XLV -0%
matured Aug 21, 19
Morgan Stanley ↗
Aug 8, 18
▼ Underweight · 🎯$60
Price at call : $24.99 — upside +140%
Today : $24.99 — upside +140%
Expected +140% · Actual +0% · Reason (≤ −15%) : ✗ No
🎯 on AVNS : 0% (15 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
0.0%
stock +0% · XLV +2%
matured Aug 8, 19
Frequently asked questions
Should I buy Avanos Medical, Inc. stock?
This isn't buy advice. For Avanos Medical, Inc., the analyst consensus is "Hold". What matters is their past reliability on this stock: the most reliable one is right 0% of the time (11 calls tracked on Avanos Medical, Inc.). We show the numbers — you decide.
Is Avanos Medical, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 3 analysts have a real record on Avanos Medical, Inc., the best hitting 0% over 11 calls. Current consensus: "Hold". Make your call on data, not noise.
What has Avanos Medical, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: AVNS performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX